基本信息
浏览量:11
职业迁徙
个人简介
My research interests are focused on methodological aspects of developing and validating multivariable prediction models. Risk prediction models can predict how a person’s disease is likely to develop (their prognosis) or their probability of developing a disease in the future, using their current characteristics like weight and blood pressure. I use applied statistics, systematic review and simulation techniques to investigate how prediction models are usually developed and validated, and how we can improve this methodology for more useful, accurate models.
Prediction models are developed using information from a group of patients, selecting the important characteristics and working out how they are associated with the outcomes of interest. After the model has been developed, it is validated using information from another, similar group of patients, to check that it works for all relevant patients. I am using an independent external validation dataset to investigate how a risk model’s performance is affected by missing data in, and the sample size of, its development dataset. I am also looking at how missing data should be dealt with when developing and validating a model.
I am also interested in how well prediction model studies are reported in the scientific literature. When important details are left out of a research article, we cannot judge how well the study was carried out and how useful the resulting model is. The TRIPOD reporting guideline was developed to help researchers fully report their prediction modelling studies. We are investigating how well prediction model studies in diabetes follow TRIPOD, to give us a baseline assessment of the quality of reporting in this area.
Most recently, I have been looking at machine learning approaches and compare them to more traditional approaches for prediction.
Prediction models are developed using information from a group of patients, selecting the important characteristics and working out how they are associated with the outcomes of interest. After the model has been developed, it is validated using information from another, similar group of patients, to check that it works for all relevant patients. I am using an independent external validation dataset to investigate how a risk model’s performance is affected by missing data in, and the sample size of, its development dataset. I am also looking at how missing data should be dealt with when developing and validating a model.
I am also interested in how well prediction model studies are reported in the scientific literature. When important details are left out of a research article, we cannot judge how well the study was carried out and how useful the resulting model is. The TRIPOD reporting guideline was developed to help researchers fully report their prediction modelling studies. We are investigating how well prediction model studies in diabetes follow TRIPOD, to give us a baseline assessment of the quality of reporting in this area.
Most recently, I have been looking at machine learning approaches and compare them to more traditional approaches for prediction.
研究兴趣
论文共 24 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Paula Dhiman,Jie Ma,Shona Kirtley, Elizabeth Mouka, Caitlin M. Waldron,Rebecca Whittle,Gary S. Collins
JOURNAL OF CLINICAL EPIDEMIOLOGY (2024): 111287-111287
BMJ (Clinical research ed.) (2024): e074819-e074819
crossref(2023)
Journal of clinical epidemiology (2023): 99-110
SSRN Electronic Journal (2023)
引用0浏览0引用
0
0
BJR openno. 1 (2023): 20220033-20220033
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn